EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

HRI Communities announces $26M funding for Touro Shakspeare redevelopment following city-funded stabilization completion.

Interim safety and efficacy data to be reported in Q1VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa ...

At the outset of the new year, LCGC International engaged with leading experts in the field to identify the major and ...

The project is expected to be highlighted as a best-practice example in future Unesco reports on the adaptive reuse of heritage buildings ...

In summary, we are making significant strides in advancing BOT/BAL and positioning Agenus for long-term success. I'll now ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more about RZLT stock here.

As the energy transition accelerates in the food and beverage (F&B) industry, on-site renewables are fast becoming an ...

Market rotation is real. As BTC decays, as ETH freezes, or memes coins run out of steam, traders tend to abandon noise in ...